BioCentury
ARTICLE | Company News

Perlegen, Mayo Clinic deal

June 21, 2004 7:00 AM UTC

Perlegen and the clinic are using Perlegen's high throughput genotyping technology and Mayo's characterized DNA samples from patients with Parkinson's disease (PD) to develop assays to detect the pres...